Insider Transactions Reported by 24 Insiders of Replimune Group, Inc.

Symbol
REPL on Nasdaq
Location
Woburn, MA

Insiders trading volume in the past year

Replimune Group, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
BAKER BROS. ADVISORS LP Director, 10%+ Owner $126M 05 Mar 2025
Omega Fund IV, L.P. 10%+ Owner $103M 14 Mar 2022
Robert Coffin Director $11.8M 16 May 2024
Philip Astley-Sparke Director $11.3M -$260K -2.25% 20 May 2025
Colin Love Chief Operating Officer $5.03M 16 May 2024
Sushil Patel Chief Executive Officer, Director $4.8M -$314K -6.14% 19 Dec 2025
Pamela Esposito Chief Business Officer $2.88M 11 Sep 2023
Konstantinos Xynos Chief Medical Officer $1.8M -$130K -6.76% 19 Dec 2025
Emily Luisa Hill Chief Financial Officer $1.75M -$69.6K -3.83% 19 Dec 2025
Tanya Lewis Chief Dev. Op. Officer $1.48M 13 Jun 2023
Christopher Sarchi Chief Commercial Officer $1.42M -$77.6K -5.18% 19 Dec 2025
Jean M. Franchi Chief Financial Officer $1.41M 16 May 2023
Andrew Schwendenman Chief Accounting Officer $704K -$26.5K -3.62% 19 Dec 2025
Kapil Dhingra Director $0 -$33K -100% 09 Dec 2025
Hyam Levitsky Director 01 Apr 2024
Madhavan Balachandran Director 01 Apr 2025
Paolo Pucci Director 01 Apr 2025
Christy J. Oliger Director 01 Apr 2025
Jason P. Rhodes Director 01 Apr 2022
MICHAEL GOLLER Director 05 Mar 2025
Veleka Peeples-Dyer Director 01 Apr 2025
Hugo Alexander Slootweg Director 01 Apr 2023
Dieter Weinand Director 01 Apr 2025
JOSEPH P. SLATTERY Director 01 Apr 2025

Recent Insider Transactions by Companies or Individuals for Replimune Group, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.